131 related articles for article (PubMed ID: 4950580)
1. The hemopoietic action of androstanes.
Sanchez-Medal L
Prog Hematol; 1971; 7():111-36. PubMed ID: 4950580
[No Abstract] [Full Text] [Related]
2. Use of androgens in hematologic disease.
Fried W
Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723
[No Abstract] [Full Text] [Related]
3. [Long-term study on the treatment of bone marrow insufficiencies using androgens].
Najean Y; Dresch C; Laprevotte I
Munch Med Wochenschr; 1971 Jun; 113(25):955-60. PubMed ID: 5108719
[No Abstract] [Full Text] [Related]
4. [Therapy of hematologic diseases using androgens].
Sánchez-Medal L
Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
[No Abstract] [Full Text] [Related]
5. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
6. Oxymetholone treatment for the anemia of bone marrow failure.
Alexanian R; Nadell J; Alfrey C
Blood; 1972 Sep; 40(3):353-65. PubMed ID: 5056967
[No Abstract] [Full Text] [Related]
7. [Androstanes in clinical hematology].
Sánchez-Medal L
Rev Clin Esp; 1971 Mar; 120(6):535-8. PubMed ID: 5164711
[No Abstract] [Full Text] [Related]
8. Oxymetholone therapy in aplastic and other refractory anaemias.
Sacks P; Gale D; Bothwell TH; Stevens K
S Afr Med J; 1972 Oct; 46(43):1607-15. PubMed ID: 4509113
[No Abstract] [Full Text] [Related]
9. Oxymetholone in refractory anaemia.
McCredie KB
Br J Haematol; 1969 Sep; 17(3):265-73. PubMed ID: 5806436
[No Abstract] [Full Text] [Related]
10. [Oxymetholone treatment in refractory anemia].
Killander A; Wadman B
Nord Med; 1971 Jul; 86(27):835. PubMed ID: 5558476
[No Abstract] [Full Text] [Related]
11. Effects of androstanes on aplastic anemia--a prospective study.
Hirota Y
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1341-59. PubMed ID: 7342641
[No Abstract] [Full Text] [Related]
12. [Refractory anemias--classification and treatment].
Lockner D
Lakartidningen; 1976 Oct; 73(42):3529-32. PubMed ID: 979416
[No Abstract] [Full Text] [Related]
13. [Androgens in hematology].
Sanchez-Medal L
Cah Med; 1971 May; 12(7):515-22. PubMed ID: 5562270
[No Abstract] [Full Text] [Related]
14. Reticuloendothelial scans in disorders involving the bone marrow.
Schreiner DP
J Nucl Med; 1974 Dec; 15(12):1158-62. PubMed ID: 4610099
[No Abstract] [Full Text] [Related]
15. Bone-marrow failure: diagnosis and treatment.
Gordon-Smith EC
Br J Haematol; 1972 Sep; 23():Suppl:167-75. PubMed ID: 4647405
[No Abstract] [Full Text] [Related]
16. Androgens and erythropoiesis.
Shahidi NT
N Engl J Med; 1973 Jul; 289(2):72-80. PubMed ID: 4575719
[No Abstract] [Full Text] [Related]
17. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
[TBL] [Abstract][Full Text] [Related]
18. Oxymetholone in myelofibrosis and chronic lymphocytic leukemia.
Presant CA; Safdar SH
Arch Intern Med; 1973 Aug; 132(2):175-8. PubMed ID: 4719544
[No Abstract] [Full Text] [Related]
19. The onset of a refractory response to androgens in the anemia of bone marrow failure.
Gardner FH; Besa EC
Trans Am Clin Climatol Assoc; 1977; 88():108-18. PubMed ID: 898530
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of the therapeutic use of a thymus extract with antileukopenic action].
Bernasconi C
Minerva Med; 1970 Sep; 61(72):3796-804. PubMed ID: 5454447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
